Patent Assignment
Reel/Frame 075874/0883
Release of Security Interest
Recorded: 2026-07-01
Pages: 14
Assignor
WILMINGTON SAVINGS FUND SOCIETY, FSB
Executed: 2026-06-29
Assignees
CURRAX PHARMACEUTICALS LLC
10 NORTH PARK PLACE, SUITE 201, MORRISTOWN, NEW JERSEY, 07960
NALPROPION PHARMACEUTICALS LLC
155 FRANKLIN ROAD, SUITE 450, BRENTWOOD, TENNESSEE, 37027
Covered Properties
(74)
Methods of Improving the Pharmacokinetics of Doxepin
Low-Dose Doxepin Formulations And Methods Of Making And Using The Same
Ultra Low Dose Doxepin and Methods of Using the Same to Treat Sleep Disorders
Methods Of Using Low-Dose Doxepin For The Improvement Of Sleep
Doxepin Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders
Doxepin Trans Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders
Methods of Using Low-Dose Doxepin for the Improvement of Sleep
Application:
13/764,467 →
Publication:
US US20130150434A1
Low-Dose Doxepin for Treatment of Sleep Disorders in Elderly Patients
Methods of Treating Insomnia Using a Combination Therapy of Low-Dose Doxepin and Zolpidem
Low Dose Doxepin Formulations, Including Buccal, Sublingual And Fastmelt Formulations, And Uses Of The Same To Treat Insomnia
Application:
16/686,113 →
Publication:
US US20200078295A1
Phosphate-Binding Chitosan and Uses Thereof
Application:
13/544,775 →
Publication:
US US20120277183A1
Methods For Administering Weight Loss Medications
Application:
16/428,069 →
Publication:
US US20190282503A1
Compositions and Methods for Reducing Food Cravings
Application:
15/411,585 →
Publication:
US US20170312269A1
Increasing Drug Bioavailability In Naltrexone Therapy
Application:
16/534,509 →
Publication:
US US20190358222A1
Compositions And Methods For Increasing Insulin Sensitivity
Application:
16/378,177 →
Publication:
US US20190231852A1
Methods of Treating Overweight and Obesity
Compositions And Methods For Weight Loss In At Risk Patient Populations
Compositions And Methods For Reducing Major Adverse Cardiovascular Events
Methods Of Providing Weight Loss Therapy In Patients With Major Depression
Sustained Release Formulation Of Naltrexone
Application:
16/284,453 →
Publication:
US US20190183883A1
Layered Pharmaceutical Formulations
Application:
14/988,556 →
Publication:
US US20160338965A1
Methods for Treating Visceral Fat Conditions
Compositions For Affecting Weight Loss
Methods for Reducing Binge or Compulsive Eating
Application:
13/991,372 →
Publication:
US US20130252995A1
Hyaluronate Compositions
Application:
15/948,598 →
Publication:
US US20180303777A1
Methods of Improving the Pharmacokinetics of Doxepin
Methods of Improving the Pharmacokinetics of Doxepin
Low-Dose Doxepin Formulations and Methods of Making and Using the Same
Low-Dose Doxepin Formulations and Methods of Making and Using the Same
Ultra Low Dose Doxepin and Methods of Using the Same to Treat Sleep Disorders
Methods of Using Low-Dose Doxepin for the Improvement of Sleep
Methods of Using Low-Dose Doxepin for the Improvement of Sleep
Methods Of Using Low-Dose Doxepin For The Improvement Of Sleep
Methods of Using Low-Dose Doxepin for the Improvement of Sleep
Methods of Using Low-Dose Doxepin for the Improvement of Sleep
Doxepin Isomers and Isomeric Mixtures and Methods of Using the Same to Treat Sleep Disorders
Doxepin Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders
Doxepin Trans Isomers and Isomeric Mixtures and Methods of Using the Same to Treat Sleep Disorders
Doxepin Trans Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders
Doxepin Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders
Doxepin Trans Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders
Process for Preparing Tannate Liquid and Semi-Solid Dosage Forms
Process for Preparing Tannate Tablet, Capsule or Other Solid Dosage Forms
Tannate Compositions, Methods of Making and Methods of Use
Hyaluronate Compositions
Hyaluronate Compositions
Hyaluronate Compositions
Phosphate-Binding Chitosan and Uses Thereof
Phosphate-Binding Magnesium Salts and Uses Thereof
Phosphate-Binding Magnesium Salts And Uses Thereof
Phosphate-Binding Magnesium Salts And Uses Thereof
Crystal Polymorph of Magnesium Glycinate Dihydrate and Process for Its Preparation
Crystal Polymorph of Magnesium Glycinate Dihydrate and Process for Its Preparation
Methods for Administering Weight Loss Medications
Methods for Administering Weight Loss Medications
Methods For Administering Weight Loss Medications
Compositions and methods for increasing insulin sensitivity
Compositions and Methods for Increasing Insulin Sensitivity
Methods of Treating Overweight and Obesity
Methods of Treating Overweight and Obesity
Compositions and Methods for Weight Loss in at Risk Patient Populations
Patent:
8,969,371 →
Application:
14/322,810 →
Compositions and Methods for Weight Loss in at Risk Patient Populations
Compositions and Methods for Weight Loss in at Risk Patient Populations
Compositions and Methods for Weight Loss in at Risk Patient Populations
Compositions and Methods for Reducing Major Adverse Cardiovascular Events
Methods of Providing Weight Loss Therapy in Patients with Major Depression
Sustained Release Formulation of Naltrexone
Layered Pharmaceutical Formulations
Layered Pharmaceutical Formulations
Compositions for Affecting Weight Loss
Compositions for Affecting Weight Loss
Compositions for Affecting Weight Loss
Methods of Providing Weight Loss Therapy in Patients with Major Depression
Sustained Release Formulation of Naltrexone
Related Assignments
(22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 12, 2012
From: LEWIS, ROBERT L.; DAY, CHARLES E.
To: CYPRESS PHARMACEUTICAL, INC.
Reel/Frame 029119/0425 →
Security Agreement
Jan 3, 2013
From: CYPRESS PHARMACEUTICALS, INC.
To: MIDCAP FUNDING V, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 029569/0012 →
Security Agreement
May 17, 2013
From: PERNIX SLEEP, INC.
To: MIDCAP FINANCIAL, LLC
Reel/Frame 030441/0229 →
Patent Transfer and Assignment
Sep 13, 2013
From: MIDCAP FUNDING V, LLC
To: MIDCAP FINANCIAL, LLC
Reel/Frame 031266/0437 →
Patent Transfer and Assignment
Sep 13, 2013
From: MIDCAP FINANCIAL, LLC
To: MIDCAP FUNDING IV, LLC
Reel/Frame 031266/0572 →
Stock Power/Stock Certificates
Jan 17, 2014
From: CYPRESS PHARMACEUTICALS, INC.
To: PERNIX THERAPEUTICS HOLDINGS, INC.
Reel/Frame 032076/0271 →
Merger
Feb 3, 2014
From: SOMAXON PHARMACEUTICALS, INC.
To: PERNIX THERAPEUTICS HOLDINGS, INC.
Reel/Frame 032118/0272 →
Release of Security Interest in Patent Rights Reel/Frame 030441/0229
Feb 24, 2014
From: MIDCAP FUNDING IV, LLC (SUCCESSOR IN INTEREST TO MIDCAP FINANCIAL, LLC)
To: PERNIX SLEEP, INC.
Reel/Frame 032330/0023 →
Release of Security Interest in Patent Rights Reel/Frame 029569/0012
Feb 24, 2014
From: MIDCAP FUNDING IV, LLC (SUCCESSOR IN INTEREST TO MIDCAP FUNDING V, LLC)
To: CYPRESS PHARMACEUTICALS, INC.
Reel/Frame 032330/0060 →
Assignment of Assignor's Interest
Aug 21, 2015
From: PERNIX THERAPEUTICS HOLDINGS, INC.
To: CYPRESS PHARMACEUTICALS, INC.
Reel/Frame 036387/0660 →
Assignment of Assignor's Interest
Aug 21, 2015
From: PERNIX THERAPEUTICS HOLDINGS, INC.
To: PERNIX SLEEP, INC.
Reel/Frame 036387/0667 →
Merger
Jun 6, 2016
From: SOMAXON PHARMACEUTICALS, INC.
To: PERNIX SLEEP, INC.
Reel/Frame 038813/0079 →
Assignment of Assignor's Interest
Mar 24, 2017
From: MCKINNEY, ANTHONY A.; TOLLEFSON, GARY; COWLEY, MICHAEL A.
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 041734/0789 →
Security Interest
Aug 6, 2018
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 047288/0321 →
Assignment of Assignor's Interest
Oct 24, 2018
From: OREXIGEN THERAPEUTICS, INC.
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 048029/0908 →
Security Interest
May 6, 2019
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 049092/0156 →
Assignment of Assignor's Interest
May 31, 2019
From: PERNIX SLEEP, INC.
To: CURRAX PHARMACEUTICALS LLC
Reel/Frame 049329/0730 →
Assignment of Assignor's Interest
May 31, 2019
From: CYPRESS PHRAMACEUTICALS, INC.
To: CURRAX PHARMACEUTICALS LLC
Reel/Frame 049329/0945 →
Release of Security Interest
Sep 27, 2019
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 050520/0149 →
Release of Security Interest
Sep 27, 2019
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 050574/0106 →
Change of Name
Oct 17, 2019
From: NALPROPION PHARMACEUTICALS, INC.
To: NALPROPION PHARMACEUTICALS LLC
Reel/Frame 050750/0497 →
Security Interest
Dec 19, 2019
From: CURRAX PHARMACEUTICALS LLC; NALPROPION PHARMACEUTICALS LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 051377/0958 →